
|Articles|January 1, 2007
- Volume 0 0
DRUG COMPANY OFFERS SAVINGS FOR PART D ENROLLEES
Advertisement
AstraZeneca recently launched AZ Medicine &Me for Medicare Part D beneficiaries who may havedifficulty affording their medications. Individualswho qualify and enroll will be able to visit their participatinglocal pharmacy and receive immediatesavings on AstraZeneca products.
To qualify for the program, an individual mustmeet the following criteria:
- Enroll in Medicare Part D
- Have an annual individual income at or below$30,000 (or an annual income at or below$40,000 per couple)
- Take AstraZeneca medications
- Have spent at least 3% of annual householdincome on prescription drugs during the calendaryear
Individuals who qualify for the program will pay nomore than $25 for a typical 30-day supply of theirAstraZeneca medicine and will receive the assistanceat the pharmacy counter immediately.
Articles in this issue
almost 20 years ago
Preventing Rasagiline Drug Interactionsalmost 20 years ago
nacds SPEAKS OUT: Specialty Pharmaceuticals on the Risealmost 20 years ago
Strategies for Coping with Alzheimer's Diseasealmost 20 years ago
Captive at the Counter: When Robbers Take Hostages—Part 1almost 20 years ago
A Third Category? Medicines Go Behind the Counteralmost 20 years ago
Avoiding Common Dispensing Errorsalmost 20 years ago
Pharm School Receives Grant to Help with Part Dalmost 20 years ago
compounding HOTLINEalmost 20 years ago
The Pharmacist's Role in the Management of Alzheimer's Diseasealmost 20 years ago
A Challenging Path to a PharmD DegreeAdvertisement
Related to this article

Payer requirements, prescriber habits, and operational realities ultimately determine which ICI patients receive.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
How Stanford Pharmacists Help Close Heart Failure Therapy Gaps
3
GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers
4
GLP-1 Receptor Agonists and Cancer: Considerations for Specialty Pharmacists
5